"World's Most Complete Market Research Reports Repository"

Global Anti-Infective Vaccines Market Insights, Forecast to 2025

This report studies the global market size of Anti-Infective Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Infective Vaccines in these regions.
This research report categorizes the global Anti-Infective Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Anti-infective vaccines are the most effective public health measure taken to fight infectious diseases.
In 2017, the global Anti-Infective Vaccines market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Anti-Infective Vaccines market based on company, product type, application and key regions.

The various contributors involved in the value chain of Anti-Infective Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-Infective Vaccines include
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech

Market Size Split by Type
Inactivated vaccines
Conjugate vaccines
Live/attenuated vaccines
Market Size Split by Application
Bacterial diseases
Viral diseases

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Anti-Infective Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Anti-Infective Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-Infective Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-Infective Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anti-Infective Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-Infective Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Infective Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Anti-Infective Vaccines Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-Infective Vaccines Market Size Growth Rate by Type
1.4.2 Inactivated vaccines
1.4.3 Conjugate vaccines
1.4.4 Live/attenuated vaccines
1.5 Market by Application
1.5.1 Global Anti-Infective Vaccines Market Size Growth Rate by Application
1.5.2 Bacterial diseases
1.5.3 Viral diseases
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Anti-Infective Vaccines Market Size
2.1.1 Global Anti-Infective Vaccines Revenue 2016-2025
2.1.2 Global Anti-Infective Vaccines Sales 2016-2025
2.2 Anti-Infective Vaccines Growth Rate by Regions
2.2.1 Global Anti-Infective Vaccines Sales by Regions
2.2.2 Global Anti-Infective Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Anti-Infective Vaccines Sales by Manufacturers
3.1.1 Anti-Infective Vaccines Sales by Manufacturers
3.1.2 Anti-Infective Vaccines Sales Market Share by Manufacturers
3.1.3 Global Anti-Infective Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Infective Vaccines Revenue by Manufacturers
3.2.1 Anti-Infective Vaccines Revenue by Manufacturers (2016-2018)
3.2.2 Anti-Infective Vaccines Revenue Share by Manufacturers (2016-2018)
3.3 Anti-Infective Vaccines Price by Manufacturers
3.4 Anti-Infective Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Infective Vaccines Product Category
3.4.3 Date of International Manufacturers Enter into Anti-Infective Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Anti-Infective Vaccines Sales by Type
4.2 Global Anti-Infective Vaccines Revenue by Type
4.3 Anti-Infective Vaccines Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Anti-Infective Vaccines Breakdown Data by Application

6 North America
6.1 North America Anti-Infective Vaccines by Countries
6.1.1 North America Anti-Infective Vaccines Sales by Countries
6.1.2 North America Anti-Infective Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-Infective Vaccines by Type
6.3 North America Anti-Infective Vaccines by Application
6.4 North America Anti-Infective Vaccines by Company

7 Europe
7.1 Europe Anti-Infective Vaccines by Countries
7.1.1 Europe Anti-Infective Vaccines Sales by Countries
7.1.2 Europe Anti-Infective Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Infective Vaccines by Type
7.3 Europe Anti-Infective Vaccines by Application
7.4 Europe Anti-Infective Vaccines by Company

8 Asia Pacific
8.1 Asia Pacific Anti-Infective Vaccines by Countries
8.1.1 Asia Pacific Anti-Infective Vaccines Sales by Countries
8.1.2 Asia Pacific Anti-Infective Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-Infective Vaccines by Type
8.3 Asia Pacific Anti-Infective Vaccines by Application
8.4 Asia Pacific Anti-Infective Vaccines by Company

9 Central & South America
9.1 Central & South America Anti-Infective Vaccines by Countries
9.1.1 Central & South America Anti-Infective Vaccines Sales by Countries
9.1.2 Central & South America Anti-Infective Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-Infective Vaccines by Type
9.3 Central & South America Anti-Infective Vaccines by Application
9.4 Central & South America Anti-Infective Vaccines by Company

10 Middle East and Africa
10.1 Middle East and Africa Anti-Infective Vaccines by Countries
10.1.1 Middle East and Africa Anti-Infective Vaccines Sales by Countries
10.1.2 Middle East and Africa Anti-Infective Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-Infective Vaccines by Type
10.3 Middle East and Africa Anti-Infective Vaccines by Application
10.4 Middle East and Africa Anti-Infective Vaccines by Company

11 Company Profiles
11.1 Emergent BioDefense Operations Lansing Inc.
11.1.1 Emergent BioDefense Operations Lansing Inc. Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.1.4 Anti-Infective Vaccines Product Description
11.1.5 Recent Development
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.2.4 Anti-Infective Vaccines Product Description
11.2.5 Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.3.4 Anti-Infective Vaccines Product Description
11.3.5 Recent Development
11.4 MedImmune LLC
11.4.1 MedImmune LLC Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.4.4 Anti-Infective Vaccines Product Description
11.4.5 Recent Development
11.5 Novartis Vaccines
11.5.1 Novartis Vaccines Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.5.4 Anti-Infective Vaccines Product Description
11.5.5 Recent Development
11.6 Diagnostics Ltd.
11.6.1 Diagnostics Ltd. Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.6.4 Anti-Infective Vaccines Product Description
11.6.5 Recent Development
11.7 Intercell Biomedical
11.7.1 Intercell Biomedical Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.7.4 Anti-Infective Vaccines Product Description
11.7.5 Recent Development
11.8 MassBiologics
11.8.1 MassBiologics Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.8.4 Anti-Infective Vaccines Product Description
11.8.5 Recent Development
11.9 Barr Labs, Inc.
11.9.1 Barr Labs, Inc. Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.9.4 Anti-Infective Vaccines Product Description
11.9.5 Recent Development
11.10 Organon Teknika Co.
11.10.1 Organon Teknika Co. Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Anti-Infective Vaccines
11.10.4 Anti-Infective Vaccines Product Description
11.10.5 Recent Development
11.11 GlaxoSmithKline Biologicals
11.12 CSL Ltd.
11.13 ID Biomedical Co.
11.14 Protein Sciences Co.
11.15 Wyeth Pharmaceuticals, Inc.
11.16 Berna Biotech

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Anti-Infective Vaccines Raw Material
13.1.2 Anti-Infective Vaccines Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Picture of Anti-Infective Vaccines
Figure Global Anti-Infective Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Anti-Infective Vaccines Production Market Share by Types (Product Category) in 2017
Figure Inactivated vaccines Product Picture
Table Major Manufacturers of Inactivated vaccines
Figure Conjugate vaccines Product Picture
Table Major Manufacturers of Conjugate vaccines
Figure Live/attenuated vaccines Product Picture
Table Major Manufacturers of Live/attenuated vaccines
Table Global Anti-Infective Vaccines Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Bacterial diseases
Figure Viral diseases
Figure Anti-Infective Vaccines Report Years Considered
Figure Global Anti-Infective Vaccines Market Size 2016-2025 (Million US$)
Figure Global Anti-Infective Vaccines Sales 2016-2025 (K Units)
Table Global Anti-Infective Vaccines Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Anti-Infective Vaccines Sales by Regions 2016-2025 (K Units)
Table Global Anti-Infective Vaccines Sales Market Share by Regions 2016-2025
Figure Global Anti-Infective Vaccines Sales Market Share by Regions 2016-2025
Figure 2017 Global Anti-Infective Vaccines Sales Market Share by Regions
Table Global Anti-Infective Vaccines Revenue by Regions 2016-2025 (Million US$)
Table Global Anti-Infective Vaccines Revenue Market Share by Regions 2016-2025
Figure Global Anti-Infective Vaccines Revenue Market Share by Regions 2016-2025
Figure 2017 Global Anti-Infective Vaccines Revenue Market Share by Regions
Table Global Anti-Infective Vaccines Sales by Manufacturers (2016-2018) (K Units)
Table Global Anti-Infective Vaccines Sales Share by Manufacturers (2016-2018)
Figure Global Anti-Infective Vaccines Sales Share by Manufacturers in 2017
Table Anti-Infective Vaccines Revenue by Manufacturers (2016-2018) (Million US$)
Table Anti-Infective Vaccines Revenue Share by Manufacturers (2016-2018)
Figure Anti-Infective Vaccines Value Share by Manufacturers in 2017
Table Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Anti-Infective Vaccines Price (2016-2018) (USD/Unit)
Table Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-Infective Vaccines Product Category
Table Date of International Manufacturers Enter into Anti-Infective Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-Infective Vaccines Sales by Type (2016-2025) (K Units)
Table Global Anti-Infective Vaccines Sales Share by Type (2016-2025)
Figure Global Anti-Infective Vaccines Sales Market Share by Type (2016-2025)
Figure Global Anti-Infective Vaccines Sales Market Share by Type in 2017
Table Global Anti-Infective Vaccines Revenue by Type (2016-2025) (Million US$)
Table Global Anti-Infective Vaccines Revenue Share by Type (2016-2025)
Figure Global Anti-Infective Vaccines Revenue Market Share by Type (2016-2025)
Figure Global Anti-Infective Vaccines Revenue Market Share by Type in 2017
Table Anti-Infective Vaccines Price by Type 2013-2018 (USD/Unit)
Table Global Anti-Infective Vaccines Sales by Application (2016-2025) (K Units)
Table Global Anti-Infective Vaccines Sales Share by Application (2016-2025)
Figure Global Sales Anti-Infective Vaccines Market Share by Application (2016-2025)
Figure Global Sales Anti-Infective Vaccines Market Share by Application (2016-2025)
Figure North America Anti-Infective Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure North America Anti-Infective Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table North America Anti-Infective Vaccines Sales by Countries (2016-2025) (K Units)
Table North America Anti-Infective Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 North America Anti-Infective Vaccines Sales Market Share by Countries
Table North America Anti-Infective Vaccines Revenue by Countries (2016-2025) (Million US$)
Table North America Anti-Infective Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Anti-Infective Vaccines Revenue Market Share by Countries
Figure United States Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure United States Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Canada Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table North America Anti-Infective Vaccines Sales by Type (2016-2025) (K Units)
Table North America Anti-Infective Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 North America Anti-Infective Vaccines Market Share by Type
Table North America Anti-Infective Vaccines Sales by Application (2016-2025) (K Units)
Table North America Anti-Infective Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 North America Anti-Infective Vaccines Market Share by Application
Table North America Anti-Infective Vaccines Sales by Company (2016-2018) (K Units)
Table North America Anti-Infective Vaccines Sales Market Share by Company (2016-2018)
Figure North America Anti-Infective Vaccines Sales Market Share by Company in 2017
Figure Europe Anti-Infective Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Europe Anti-Infective Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Anti-Infective Vaccines Sales by Countries (2016-2025) (K Units)
Table Europe Anti-Infective Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Anti-Infective Vaccines Sales Market Share by Countries
Table Europe Anti-Infective Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Europe Anti-Infective Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Anti-Infective Vaccines Revenue Market Share by Countries
Figure Germany Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Germany Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure France Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure France Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure UK Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure UK Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Italy Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Russia Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Anti-Infective Vaccines Sales by Type (2016-2025) (K Units)
Table Europe Anti-Infective Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Europe Anti-Infective Vaccines Market Share by Type
Table Europe Anti-Infective Vaccines Sales by Application (2016-2025) (K Units)
Table Europe Anti-Infective Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Europe Anti-Infective Vaccines Market Share by Application
Table Europe Anti-Infective Vaccines Sales by Company (2016-2018) (K Units)
Table Europe Anti-Infective Vaccines Sales Market Share by Company (2016-2018)
Figure Europe Anti-Infective Vaccines Sales Market Share by Company in 2017
Figure Asia Pacific Anti-Infective Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Anti-Infective Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Anti-Infective Vaccines Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Anti-Infective Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Anti-Infective Vaccines Sales Market Share by Countries
Table Asia Pacific Anti-Infective Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Anti-Infective Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Anti-Infective Vaccines Revenue Market Share by Countries
Figure China Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure China Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Japan Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Korea Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure India Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure India Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Australia Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Anti-Infective Vaccines Sales by Type (2016-2025) (K Units)
Table Asia Pacific Anti-Infective Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Anti-Infective Vaccines Market Share by Type
Table Asia Pacific Anti-Infective Vaccines Sales by Application (2016-2025) (K Units)
Table Asia Pacific Anti-Infective Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Anti-Infective Vaccines Market Share by Application
Table Asia Pacific Anti-Infective Vaccines Sales by Company (2016-2018) (K Units)
Table Asia Pacific Anti-Infective Vaccines Sales Market Share by Company (2016-2018)
Figure Asia Pacific Anti-Infective Vaccines Sales Market Share by Company in 2017
Figure Central & South America Anti-Infective Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Anti-Infective Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Anti-Infective Vaccines Sales by Countries (2016-2025) (K Units)
Table Central & South America Anti-Infective Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Anti-Infective Vaccines Sales Market Share by Countries
Table Central & South America Anti-Infective Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Anti-Infective Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Anti-Infective Vaccines Revenue Market Share by Countries
Figure Brazil Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Anti-Infective Vaccines Sales by Type (2016-2025) (K Units)
Table Central & South America Anti-Infective Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Anti-Infective Vaccines Market Share by Type
Table Central & South America Anti-Infective Vaccines Sales by Application (2016-2025) (K Units)
Table Central & South America Anti-Infective Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Anti-Infective Vaccines Market Share by Application
Table Central & South America Anti-Infective Vaccines Sales by Company (2016-2018) (K Units)
Table Central & South America Anti-Infective Vaccines Sales Market Share by Company (2016-2018)
Figure Central & South America Anti-Infective Vaccines Sales Market Share by Company in 2017
Figure Middle East and Africa Anti-Infective Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Anti-Infective Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Anti-Infective Vaccines Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Anti-Infective Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Anti-Infective Vaccines Sales Market Share by Countries
Table Middle East and Africa Anti-Infective Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Countries
Figure GCC Countries Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Anti-Infective Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Anti-Infective Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Anti-Infective Vaccines Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Anti-Infective Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Anti-Infective Vaccines Market Share by Type
Table Middle East and Africa Anti-Infective Vaccines Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Anti-Infective Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Anti-Infective Vaccines Market Share by Application
Table Middle East and Africa Anti-Infective Vaccines Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Anti-Infective Vaccines Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Anti-Infective Vaccines Sales Market Share by Company in 2017
Table Emergent BioDefense Operations Lansing Inc. Company Details
Table Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Emergent BioDefense Operations Lansing Inc. Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Pasteur Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck & Co. Recent Development
Table MedImmune LLC Company Details
Table MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table MedImmune LLC Recent Development
Table Novartis Vaccines Company Details
Table Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Vaccines Recent Development
Table Diagnostics Ltd. Company Details
Table Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Diagnostics Ltd. Recent Development
Table Intercell Biomedical Company Details
Table Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Intercell Biomedical Recent Development
Table MassBiologics Company Details
Table MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table MassBiologics Recent Development
Table Barr Labs, Inc. Company Details
Table Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Barr Labs, Inc. Recent Development
Table Organon Teknika Co. Company Details
Table Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Organon Teknika Co. Recent Development
Table GlaxoSmithKline Biologicals Company Details
Table CSL Ltd. Company Details
Table ID Biomedical Co. Company Details
Table Protein Sciences Co. Company Details
Table Wyeth Pharmaceuticals, Inc. Company Details
Table Berna Biotech Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Anti-Infective Vaccines Value Chain
Table Typical Suppliers of Key Anti-Infective Vaccines Raw Material
Table Anti-Infective Vaccines Customers List
Table Anti-Infective Vaccines Sales Channels
Table Anti-Infective Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type